Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Angle News

    0,1964 $ - -
    In : 0,1837 € | 24.04.24 06:00:00 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A0B7QK
    ISIN: GB0034330679
    US-Symbol: ANPCF
    Typ: Aktie

    Angle News

    27.06.22 - ACCESSWIRE
    Angle PLC Announces Spread of Breast Cancer Accelerates During Sleep
    BREAKTHROUGH RESEARCH WITH PARSORTIX REVEALS SPREAD OF BREAST CANCER ACCELERATES DURING SLEEP
    28.04.22 - ACCESSWIRE
    Angle PLC Announces Preliminary Results
    Preliminary Results for the year ended 31 December 2021
    20.04.22 - ACCESSWIRE
    Angle PLC Announces Notice of Preliminary Results and Webcast
    GUILDFORD, UK / ACCESSWIRE / April 20, 2022 / ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-​leading liquid biopsy company, will be releasing its preliminary results for the year ...
    14.04.22 - ACCESSWIRE
    Angle PLC Announces Poster on Parsortix System Presented at AACR 2022
    PARSORTIX SYSTEM RESULTS PUBLISHED AS A POSTER AT LEADING CANCER CONFERENCE AACR 2022
    01.04.22 - ACCESSWIRE
    Angle PLC Announces Identifying Drug Targets in Cancer Metastasis
    PARSORTIX SYSTEM DEMONSTRATES ABILITY TO ISOLATE CTCs FOR DOWNSTREAM MOLECULAR ANALYSIS, IDENTIFYING KEY DRUG TARGETS INVOLVED IN CANCER ...
    29.03.22 - ACCESSWIRE
    Angle PLC Announces Rapid Information on Patient Response to Therapies
    PARSORTIX SYSTEM SHOWS POTENTIAL FOR PROVIDING RAPID INFORMATION ON PATIENT RESPONSE TO THERAPIES TARGETING METASTASIS
    25.03.22 - ACCESSWIRE
    Angle PLC Announces Identifying Therapeutic Targets in TNBC Patients
    PARSORTIX SHOWS POTENTIAL FOR IDENTIFYING THERAPEUTIC TARGETS IN PATIENTS WITH TRIPLE NEGATIVE BREAST CANCER
    15.03.22 - ACCESSWIRE
    Angle PLC Announces Update on Laboratory Accreditation
    ANGLE's US clinical laboratory issued Certificate of Registration, a key step to achieving CLIA accreditation
    02.03.22 - ACCESSWIRE
    Angle PLC Announces Holding(s) in Company
    GUILDFORD, SURREY / ACCESSWIRE / March 2, 2022 / ANGLE plc (OTCQX:ANPCY )(AIM:AGL)
    18.02.22 - ACCESSWIRE
    Angle PLC Announces Issue of Equity
    Exercise of Options and Total Voting Rights
    21.01.22 - ACCESSWIRE
    Angle PLC Announces Potential in Immunotherapy Treatment Selection
    PEER-​REVIEWED PUBLICATION HIGHLIGHTS POTENTIAL FOR PARSORTIX SYSTEM IN IMMUNOTHERAPY TREATMENT SELECTION
    17.01.22 - ACCESSWIRE
    Angle PLC Announces Concordance of Parsortix with tissue biopsy
    BREAKTHROUGH STUDY DEMONSTRATES FOR THE FIRST TIME CONCORDANCE OF PARSORTIX LIQUID BIOPSY BLOOD TEST WITH INVASIVE TISSUE BIOPSY OF THE ...
    13.01.22 - ACCESSWIRE
    Angle PLC Announces Update on Lab Accreditation and Ovarian Study
    First submissions made in relation to accreditation of ANGLE clinical laboratories
    10.01.22 - ACCESSWIRE
    Angle PLC Announces Insight into Drug Resistance in NSCLC
    EPIGENETIC ALTERATIONS IN GENES FROM LIQUID BIOPSIES PROVIDE INSIGHT INTO DRUG RESISTANCE IN NON-SMALL LUNG CANCER PATIENTS
    22.12.21 - ACCESSWIRE
    Angle PLC Announces Issue of Equity
    Exercise of Options and Total Voting Rights
    01.12.21 - ACCESSWIRE
    Angle PLC Announces Issue of Equity
    Exercise of Options and Total Voting Rights
    01.12.21 - ACCESSWIRE
    Angle PLC Announces Parsortix in RNA analysis of CTCs as tool in NSCLC
    ANGLE'S PARSORTIX SYSTEM KEY TO STUDY DEMONSTRATING RNA ANALYSIS OF CTCs AS A PROGNOSTIC TOOL IN NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    26.11.21 - ACCESSWIRE
    Angle PLC Announces Issue of Equity
    Exercise of Options and Total Voting Rights
    17.11.21 - ACCESSWIRE
    Angle PLC Announces Issue of Equity
    Exercise of Options and Total Voting Rights
    15.11.21 - ACCESSWIRE
    Angle PLC Announces Issue of LTIP Options and Share Options
    Issue of LTIP Options and Share Options and adjustment in timescales for certain existing share options

    Newssuche

    Videos

    newspaper
    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »